There were an estimated 490,000 new cases of drug-resistant TB in 2016. Tuberculosis, a lung disease most often transmitted by breathing infected particles in the air, is the ninth leading cause of ...

New drugs may be needed to fight the deadliest form of tuberculosis, because it may no longer respond to current treatments. An animal study by Johns Hopkins University researchers found that an ...

An international research team headed by scientists at the University of British Columbia has demonstrated how a novel semi-synthetic compound derived from sanguinarine (SG), an alkaloid extracted ...

A modified compound taken from bloodroot, a wildflower native to North America, effectively fights multidrug-resistant tuberculosis (TB) bacteria in the test tube, according to a new study. The ...

More than 10 million people fall sick with tuberculosis (TB) every year. The disease remains the world’s biggest infectious disease killers with an estimated 1.25 million annual deaths. The disease is ...

A new study uncovers vulnerabilities in drug-resistant TB, offering hope for improved treatments. Rutgers Health research has uncovered why a relatively new antibiotic for tuberculosis (TB) works ...

Rutgers Health research has uncovered why a relatively new antibiotic for tuberculosis (TB) works against multidrug-resistant strains, potentially inspiring improved treatments and drug development ...

Here’s a look at Tuberculosis (also known as TB), an infection, caused by a bacterium called Mycobacterium tuberculosis, that usually affects the lungs. It can also infect other parts of the body ...

(RTTNews) - Johnson & Johnson (JNJ), a global health care company, has received full approval from the US FDA and the European Commission for Sirturo (bedaquiline), a treatment specifically designed ...

Rutgers Health research has uncovered why a relatively new antibiotic for tuberculosis (TB) works against multidrug-resistant strains, potentially inspiring improved treatments and drug development ...